U.S. Markets closed

Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal

The maker of Botox Allergan will be bought by Abbvie in a cash and stock deal valued at about $63 billion. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Connor Browne, a portfolio manager at Thornburg Investment Management.